Biotin anti-mouse Ly-6G/Ly-6C (Gr-1) Antibody

Pricing & Availability
Clone
RB6-8C5 (See other available formats)
Regulatory Status
RUO
Other Names
Gr-1
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
RB6-8C5_Biotin_Ly-6GslashLy-6C_Antibody_1_FC_090116
C57BL/6 mouse bone marrow stained with biotinylated Ly-6G/Ly-6C (clone RB6-8C5, filled histogram) or biotinylated Rat IgG2b, κ isotype control (open histogram), followed by streptavidin PE.
  • RB6-8C5_Biotin_Ly-6GslashLy-6C_Antibody_1_FC_090116
    C57BL/6 mouse bone marrow stained with biotinylated Ly-6G/Ly-6C (clone RB6-8C5, filled histogram) or biotinylated Rat IgG2b, κ isotype control (open histogram), followed by streptavidin PE.
Compare all formats
Cat # Size Price Save
108403 50 µg ¥7,460
108404 500 µg ¥40,180
Description

Gr-1 is a 21-25 kD protein also known as Ly-6G/Ly-6C. This myeloid differentiation antigen is a glycosylphosphatidylinositol (GPI)-linked protein expressed on granulocytes and macrophages. In bone marrow, the expression levels of Gr-1 directly correlate with granulocyte differentiation and maturation; Gr-1 is also transiently expressed on bone marrow cells in the monocyte lineage. Immature Myeloid Gr-1+ cells play a role in the development of antitumor immunity.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Raised against granulocytes of mouse origin
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with biotin under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Application

FC - Quality tested
IP, IHC, WB - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. The suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone RB6-8C5 binds with high affinity to mouse Ly-6G molecules and to a lower extent to Ly-6C19. Clone RB6-8C5 impairs the binding of anti-mouse Ly-6G clone 1A819. However, clone RB6-8C5 is able to stain in the presence of anti-mouse Ly-6C clone HK1.420.

The RB6-8C5 antibody has been used to identify peripheral blood neutrophils and deplete granulocytes in vivo. Additional reported applications (for relevant formats of this clone) include: in vitro complement-mediated cytotoxicity2, in vivo depletion3-5,9, immunoprecipitation1, immunohistochemical staining6 (including paraffin-embedded sections9,16,33-35, acetone-fixed frozen sections11 and zinc-fixed sections15), and Western blotting7. RB6-8C5 is not suitable for depletion of hepatic myeloid derived suppressor cells (MDSCs)20.

Special Note: For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 108436).

Application References

(PubMed link indicates BioLegend citation)
  1. Fleming TJ, et al. 1993. J. Immunol. 151:2399. (IP)
  2. Brummer E, et al. 1984. J. Leukocyte Biol. 36:505. (CMCD)
  3. Stoppacciaro A, et al. 1993. J. Exp. Med. 178:151. (Deplete)
  4. Tumpey TM, et al. 1996. J. Virol. 70:898. (Deplete)
  5. Czuprynski CJ, et al. 1994. J. Immunol. 152:1836. (Deplete)
  6. Nitta H, et al. 1997. Cell Vision 4:73. (IHC)
  7. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (WB)
  8. Engwerda CR, et al. 2004. Am. J. Pathol. 165:2123.
  9. Brown CR, et al. 2004. Infect. Immun. 72:4956. (Deplete, IHC)
  10. Andoniou CE, et al. 2005. Nature Immunology 6:1011. (FC) PubMed
  11. Li M, et al. 2006. P. Natl. Acad. Sci USA 103:11736. (IHC)
  12. Dzhagalov I, et al. 2007. Blood 109:1620. (FC) PubMed
  13. Fazilleau N, et al. 2007. Nature Immunol. 8:753. (FC) PubMed
  14. Heuser M, et al. 2007. Blood 110:1639. (FC) PubMed
  15. Wang T, et al. 2007. Infect. Immun. 75:1144. (IHC)
  16. Bosio CM, et al. 2007. J. Immunol. 178:4538. (IHC)
  17. Boehme SA, et al. 2009. Int. Immunol. 21:81. (IHC)
  18. Piao Y, et al. 2012. Neuro Oncol. 14:1379. PubMed
  19. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  20. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  21. Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed
  22. Fan Q, et al. 2014. Cancer Res. 74:471. PubMed
  23. Korrer MJ, et al. 2014. PLoS One. 9:91370. PubMed
  24. Morshed M, et al. 2014. J Immunol. 192:5314. PubMed
  25. Collins C, et al. 2014. PNAS. 111:9899. PubMed
  26. Madireddi S, et al. 2014. J Exp Med. 211:1433. PubMed
  27. Bianchi G, et al. 2014. Cell Death Dis. 5:1135. PubMed
  28. Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
  29. Roderick JE, et al. 2014. PNAS. 111:14436. PubMed
  30. Distel E, et al. 2014. Circ Res. 115:759. PubMed
  31. Iwai H, et al. 2015. Tuberculosis. 95:246. PubMed
  32. Charmsaz S, et al. 2015. PLoS One. 10:130692. PubMed
  33. Whiteland J, et al. 1994 J Histochem Cytochem 43:3 (IHC-P)
  34. Brown C, et al. 2003 J Immunology 171:2 (IHC-P)
  35. Obregon-Henao A, et al. PLoS One 8:11 (IHC-P)
Product Citations
  1. Ahmed AU, et al. 2017. J Immunol. 199(6):2128. PubMed
  2. Grigsby SM, et al. 2021. Cancers (Basel). 13:. PubMed
  3. Davis FM, et al. 2020. J Immunol. 2503:204. PubMed
  4. Bouchareychas L, et al. 2021. iScience. 24(8):102847. PubMed
  5. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  6. Domingues AF, et al. 2020. Elife. 9:e51754. PubMed
  7. Zhu C, et al. 2018. Sci Rep. 5.113194444. PubMed
  8. Patel MM, et al. 2018. J Am Heart Assoc. 7:e010690. PubMed
  9. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  10. Florentin J, et al. 2022. Front Immunol. 13:882484. PubMed
  11. Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed
  12. Liu M, et al. 2022. J Exp Med. 219:. PubMed
  13. Lin YH, et al. 2021. Front Immunol. 12:626418. PubMed
  14. Dubeykovskaya Z, et al. 2016. Nat Commun. 7:10517. PubMed
  15. Preglej T, et al. 2020. JCI Insight. 5(4):. PubMed
  16. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  17. Giambra V et al. 2018. Cell stem cell. 23(5):714-726 . PubMed
  18. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  19. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  20. Gutiérrez-Gutiérrez Ó, et al. 2021. EMBO Rep. 22:e52905. PubMed
  21. Scalzo S, et al. 2022. Int J Nanomedicine. 17:2865. PubMed
  22. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  23. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  24. Pokrovskii M, et al. 2020. EMBO J. 39:e104159. PubMed
  25. Hinterbrandner M, et al. 2021. JCI Insight. 6:e151797. PubMed
  26. Liu X, et al. 2021. eLife. 0.416666666666667. PubMed
  27. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  28. Li Q et al. 2018. Immunity. 48(2):258-270 . PubMed
  29. Mann M, et al. 2018. Cell Rep. 25:2992. PubMed
  30. Davis FM, et al. 2019. Arterioscler Thromb Vasc Biol. 39:2353. PubMed
  31. Mikami H, et al. 2020. Nat Commun. 11:1162. PubMed
  32. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  33. Wu HC, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  34. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  35. Sochalska M, et al. 2016. Oncogene. 10.1038/onc.2016.362. PubMed
  36. Olsson A, et al. 2016. Nature. 10.1038/nature19348. PubMed
  37. Kitano M, et al. 2016. Proc Natl Acad Sci U S A. 113: 1044 - 1049. PubMed
  38. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  39. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  40. Paiva RS, et al. 2021. Eur J Immunol. 51:1968. PubMed
  41. Jassinskaja M, et al. 2021. Cell Reports. 34(12):108894. PubMed
  42. Paiva RA, et al. 2021. Cell Reports. 35(2):108967. PubMed
  43. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  44. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  45. Khiew SH, et al. 2020. J Clin Invest. 130:3453. PubMed
  46. Köchl R, et al. 2020. Elife. 9:00. PubMed
  47. Getts D, et al. 2008. J Exp Med. 205:2319. PubMed
  48. Hurrell BP, et al. 2019. Cell Rep. 29:4509. PubMed
  49. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  50. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  51. Luo W et al. 2018. Immunity. 48(2):313-326 . PubMed
  52. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  53. Kotaki R, et al. 2020. Sci Rep. 10:13554. PubMed
  54. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  55. Dietmar Herndler‐Brandstetter et al. 2018. Immunity. 48(4):716-729 . PubMed
  56. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  57. Milner JJ, et al. 2020. Immunity. 52(5):808-824.e7. PubMed
  58. Carr M, et al. 2016. Proc Natl Acad Sci U S A. 113(52):15024-15029. PubMed
  59. Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed
  60. Ishidome T et al. 2017. EBioMedicine. 22:89-99 . PubMed
  61. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  62. Aktories P, et al. 2022. Cell Rep Methods. 2:100260. PubMed
  63. Yi W, et al. 2021. Cell Reports. 34(13):108922. PubMed
  64. Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
  65. Kubota S, et al. 2019. Nat Commun. 10:1653. PubMed
  66. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  67. Sevin M, et al. 2018. Nat Commun. 9:1431. PubMed
  68. Galle-Treger L, et al. 2020. J Allergy Clin Immunol. 145:502. PubMed
  69. Gao Y, et al. 2020. Immunity. 52(6):1007-1021.e8. PubMed
  70. Galle-Treger L, et al. 2019. Nat Commun. 10:713. PubMed
  71. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  72. Akk A, et al. 2019. Mol Immunol. 114:629. PubMed
  73. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  74. Frohner IE, et al. 2020. Cell Rep. 30:3171. PubMed
  75. Vasamsetti SB, et al. 2018. Immunity. 49:93. PubMed
  76. Lehrke MJ, et al. 2021. Elife. 10:. PubMed
  77. Zeis P, et al. 2020. Immunity. 53:775. PubMed
  78. Nasarre P, et al. 2021. Cancers (Basel). 13: . PubMed
  79. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  80. Shin JW, et al. 2020. Cell Death Dis. 0.667361111. PubMed
  81. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  82. Yokomizo-Nakano T, et al. 2020. Cancer Res. 80:2523. PubMed
  83. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  84. He M, et al. 2020. Cell Metabolism. 31(3):580-591. PubMed
  85. Bajaña S, et al. 2022. iScience. 25:103732. PubMed
  86. Michel A, et al. 2013. J Immunol. 90:5534. PubMed
  87. Lefkopoulos S, et al. 2020. Immunity. 53(5):934-951.e9. PubMed
  88. Zhang C, et al. 2018. Cell Res. 28:323. PubMed
  89. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  90. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  91. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  92. Riedel SS, et al. 2021. Molecular Cell. 81(11):2332-2348.e9. PubMed
  93. Lutz J, et al. 2015. Nat Commun. 6: 8575. PubMed
  94. Matsuzaki Y, et al. 2015. Biomed Rep. 1: 91 - 97. PubMed
  95. Säwen P et al. 2018. eLife. 7 pii: e41258. PubMed
  96. Ito K et al. 2019. Cell Rep. 28(10):2480-2490 . PubMed
  97. Luo H, et al. 2019. Cell Rep. 26:945. PubMed
  98. Morganti C, et al. 2022. EMBO Rep. 23:e54262. PubMed
  99. Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
  100. Li ZG, et al. 2020. Chin Med J (Engl). 1943:133. PubMed
  101. Teng Y, et al. 2021. Mol Ther. 29:2424. PubMed
  102. Mincham KT, et al. 2021. Front Immunol. 11:601494. PubMed
  103. Olariu V, et al. 2021. Cell Reports. 34(2):108622. PubMed
  104. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  105. Johnson JL et al. 2018. Immunity. 48(2):243-257 . PubMed
RRID
AB_313368 (BioLegend Cat. No. 108403)
AB_313369 (BioLegend Cat. No. 108404)

Antigen Details

Structure
21-25 kD
Distribution

Granulocytes, monocytes

Cell Type
Granulocytes, Monocytes, Neutrophils
Biology Area
Immunology, Innate Immunity
Antigen References

1. Fleming TJ, et al. 1993. J. Immunol. 151:2399.
2. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
3. Goni O, et al. 2002. Int. Immunol. 14:1125.

Gene ID
17067 View all products for this Gene ID 546644 View all products for this Gene ID
UniProt
View information about Ly-6G Ly-6C on UniProt.org

Related FAQs

How many biotin molecules are per antibody structure?
We don't routinely measure the number of biotins with our antibody products but the number of biotin molecules range from 3-6 molecules per antibody.

Other Formats

View All Ly-6G/Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Biotin anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC, IHC, IP, WB
FITC anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
PE anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
PE/Cyanine5 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Purified anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC, IHC, IP, WB
PE/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Alexa Fluor® 488 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC, IHC
Alexa Fluor® 647 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Alexa Fluor® 700 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Brilliant Violet 711™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
APC/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Pacific Blue™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
PerCP/Cyanine5.5 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
PerCP anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Brilliant Violet 421™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Brilliant Violet 570™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC, IP, CMCD, Depletion, IHC, WB
Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Brilliant Violet 605™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Brilliant Violet 650™ anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Alexa Fluor® 594 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 IHC-F, FC
Purified anti-mouse Ly-6G/Ly-6C (Gr-1) (Maxpar® Ready) RB6-8C5 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
APC/Fire™ 750 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
TotalSeq™-A0116 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 PG
TotalSeq™-C0116 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 PG
TotalSeq™-B0116 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 PG
Spark Blue™ 550 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
APC/Fire™ 810 anti-mouse Ly-6G/Ly-6C (Gr-1) RB6-8C5 FC
Spark Violet™ 423 anti-mouse Ly-6G/Ly-6C (GR-1) Antibody RB6-8C5 FC
Spark UV™ 387 anti-mouse Ly-6G/Ly-6C (GR-1) RB6-8C5 FC
Go To Top Version: 3    Revision Date: 09/01/2016

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Biotin anti-mouse Ly-6G/Ly-6C (Gr-1)

  • FITC anti-mouse Ly-6G/Ly-6C (Gr-1)

  • PE anti-mouse Ly-6G/Ly-6C (Gr-1)

  • PE/Cyanine5 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Purified anti-mouse Ly-6G/Ly-6C (Gr-1)

  • PE/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Alexa Fluor® 488 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Alexa Fluor® 647 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Alexa Fluor® 700 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 711™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • APC/Cyanine7 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Pacific Blue™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • PerCP/Cyanine5.5 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • PerCP anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 421™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 570™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Ultra-LEAF™ Purified anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 510™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 605™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Brilliant Violet 650™ anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Alexa Fluor® 594 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Purified anti-mouse Ly-6G/Ly-6C (Gr-1) (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • APC/Fire™ 750 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • TotalSeq™-A0116 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • TotalSeq™-C0116 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • TotalSeq™-B0116 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Spark Blue™ 550 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • APC/Fire™ 810 anti-mouse Ly-6G/Ly-6C (Gr-1)

  • Spark Violet™ 423 anti-mouse Ly-6G/Ly-6C (GR-1) Antibody

  • Spark UV™ 387 anti-mouse Ly-6G/Ly-6C (GR-1)

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account